Cargando…

Heparan sulfate: Resilience factor and therapeutic target for cocaine abuse

Substance abuse is a pressing problem with few therapeutic options. The identification of addiction resilience factors is a potential strategy to identify new mechanisms that can be targeted therapeutically. Heparan sulfate (HS) is a linear sulfated polysaccharide that is a component of the cell sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jihuan, Kawamura, Tomoya, Sethi, Manveen K., Zaia, Joseph, Repunte-Canonigo, Vez, Sanna, Pietro Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654972/
https://www.ncbi.nlm.nih.gov/pubmed/29066725
http://dx.doi.org/10.1038/s41598-017-13960-6
_version_ 1783273452400017408
author Chen, Jihuan
Kawamura, Tomoya
Sethi, Manveen K.
Zaia, Joseph
Repunte-Canonigo, Vez
Sanna, Pietro Paolo
author_facet Chen, Jihuan
Kawamura, Tomoya
Sethi, Manveen K.
Zaia, Joseph
Repunte-Canonigo, Vez
Sanna, Pietro Paolo
author_sort Chen, Jihuan
collection PubMed
description Substance abuse is a pressing problem with few therapeutic options. The identification of addiction resilience factors is a potential strategy to identify new mechanisms that can be targeted therapeutically. Heparan sulfate (HS) is a linear sulfated polysaccharide that is a component of the cell surface and extracellular matrix. Heparan sulfate modulates the activity and distribution of a set of negatively charged signaling peptides and proteins — known as the HS interactome — by acting as a co-receptor or alternative receptor for growth factors and other signaling peptides and sequestering and localizing them, among other actions. Here, we show that stimulants like cocaine and methamphetamine greatly increase HS content and sulfation levels in the lateral hypothalamus and that HS contributes to the regulation of cocaine seeking and taking. The ability of the HS-binding neuropeptide glial-cell-line-derived neurotrophic factor (GDNF) to increase cocaine intake was potentiated by a deletion that abolished its HS binding. The delivery of heparanase, the endo-β-D-glucuronidase that degrades HS, accelerated the acquisition of cocaine self-administration and promoted persistent responding during extinction. Altogether, these results indicate that HS is a resilience factor for cocaine abuse and a novel therapeutic target for the treatment of cocaine addiction.
format Online
Article
Text
id pubmed-5654972
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-56549722017-10-31 Heparan sulfate: Resilience factor and therapeutic target for cocaine abuse Chen, Jihuan Kawamura, Tomoya Sethi, Manveen K. Zaia, Joseph Repunte-Canonigo, Vez Sanna, Pietro Paolo Sci Rep Article Substance abuse is a pressing problem with few therapeutic options. The identification of addiction resilience factors is a potential strategy to identify new mechanisms that can be targeted therapeutically. Heparan sulfate (HS) is a linear sulfated polysaccharide that is a component of the cell surface and extracellular matrix. Heparan sulfate modulates the activity and distribution of a set of negatively charged signaling peptides and proteins — known as the HS interactome — by acting as a co-receptor or alternative receptor for growth factors and other signaling peptides and sequestering and localizing them, among other actions. Here, we show that stimulants like cocaine and methamphetamine greatly increase HS content and sulfation levels in the lateral hypothalamus and that HS contributes to the regulation of cocaine seeking and taking. The ability of the HS-binding neuropeptide glial-cell-line-derived neurotrophic factor (GDNF) to increase cocaine intake was potentiated by a deletion that abolished its HS binding. The delivery of heparanase, the endo-β-D-glucuronidase that degrades HS, accelerated the acquisition of cocaine self-administration and promoted persistent responding during extinction. Altogether, these results indicate that HS is a resilience factor for cocaine abuse and a novel therapeutic target for the treatment of cocaine addiction. Nature Publishing Group UK 2017-10-24 /pmc/articles/PMC5654972/ /pubmed/29066725 http://dx.doi.org/10.1038/s41598-017-13960-6 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Chen, Jihuan
Kawamura, Tomoya
Sethi, Manveen K.
Zaia, Joseph
Repunte-Canonigo, Vez
Sanna, Pietro Paolo
Heparan sulfate: Resilience factor and therapeutic target for cocaine abuse
title Heparan sulfate: Resilience factor and therapeutic target for cocaine abuse
title_full Heparan sulfate: Resilience factor and therapeutic target for cocaine abuse
title_fullStr Heparan sulfate: Resilience factor and therapeutic target for cocaine abuse
title_full_unstemmed Heparan sulfate: Resilience factor and therapeutic target for cocaine abuse
title_short Heparan sulfate: Resilience factor and therapeutic target for cocaine abuse
title_sort heparan sulfate: resilience factor and therapeutic target for cocaine abuse
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654972/
https://www.ncbi.nlm.nih.gov/pubmed/29066725
http://dx.doi.org/10.1038/s41598-017-13960-6
work_keys_str_mv AT chenjihuan heparansulfateresiliencefactorandtherapeutictargetforcocaineabuse
AT kawamuratomoya heparansulfateresiliencefactorandtherapeutictargetforcocaineabuse
AT sethimanveenk heparansulfateresiliencefactorandtherapeutictargetforcocaineabuse
AT zaiajoseph heparansulfateresiliencefactorandtherapeutictargetforcocaineabuse
AT repuntecanonigovez heparansulfateresiliencefactorandtherapeutictargetforcocaineabuse
AT sannapietropaolo heparansulfateresiliencefactorandtherapeutictargetforcocaineabuse